5092 CapSure SP Novus |
Product Characteristics | |||
|---|---|---|---|---|
| US Market Release | Jun-98 | Serial Number Prefix | LET | |
| Registered US Implants | 111,800 | Type and/or Fixation | Transvenous, Vent., Tines | |
| Estimated Active US Implants | 61,600 | Polarity | Bipolar | |
| Advisories | None | Steroid | Yes | |
| Ventricular Placement | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| System Longevity Study Results |
|
|||||||||
| Number of Leads Enrolled in Study | 1,171 | |||||||||
| Cumulative Months of Follow-Up | 41,628 | |||||||||
| Number of Leads Active in Study | 227 | |||||||||
| Qualifying Complications | 8 Total | |||||||||
| Extra Cardiac Stimulation | 1 | |||||||||
| Failure to Capture | 2 | |||||||||
| Lead Dislodgement | 5 | |||||||||
